References
- Kennedy HL, Brooks MM, Barker AH, et al. Beta-blocker therapy in Cardiac Arrhythmia Suppression Trial. Am J Cardiol 1994; 74(Oct 1): 674–80
- The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329(10): 673–82
- ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992; 339(8796): 753–70
- A statement for healthcare professionals from the American Heart Association. Cardiac rehabilitation programs. Circulation 1994; 90(3): 1602–10
- Rouleau JL, Moye LA, Pfeffer MA, et al, for the SAVE Investigators. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med 1993: 328(11): 779–84
- Pfeffer MA, Moye LA, Braunwald E, et al, for the SAVE Investigators. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. JAMA 1991; 266(4): 528–32
- Collins R, Julian D. British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction. Br Heart J 1991; 66(3): 250–5